Open access
145
Views
15
CrossRef citations to date
0
Altmetric
Original Research
Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
Peter MA Calverley1 Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UKCorrespondence[email protected]
, Antonio R Anzueto2 Pulmonary/Critical Care, University of Texas and South Texas Veterans Health Care System, San Antonio, TX, USA
, Daniel Dusser3 Department of Pneumology, Hôpital Cochin, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
, Achim Mueller4 Biostatistics and Data Sciences Europe, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
, Norbert Metzdorf5 Respiratory Medicine, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
& Robert A Wise6 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Pages 1297-1308
|
Published online: 23 Apr 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.